Search - tctmd.com

Displaying 281 - 300 of 1109

Sort: Relevancy | Date

News Daily News

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Michael O'Riordan

June 14, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

大规模 Meta 分析显示，TAVR 与手术 30 天和 1 年死亡率相当

Michael O'Riordan

June 07, 2016

News Daily News

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

Michael O'Riordan

June 07, 2016

News Daily News

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Michael O'Riordan

June 06, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Industry News

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

June 06, 2016

News Conference News EuroPCR 2016

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Shelley Wood

May 26, 2016

News Conference News EuroPCR 2016

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access

Michael O'Riordan

May 19, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Daily News

尽管有指南说明，但糖尿病患者多支 CAD 患者接受 PCI 的人数仍多于 CABG

Yael L. Maxwell

May 13, 2016

News Daily News

A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG

Yael L. Maxwell

May 13, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

News Daily News

高风险 PCI 的机械循环支持：设备、时间、术者和方式的指南

Todd Neale

May 05, 2016

News Daily News

Soporte Circulatorio Mecánico en PCI de Alto Riesgo: Guía para Saber Cuándo y Cómo

Todd Neale

May 05, 2016

News Daily News

¿Predilatación o No Predilatación en TAVR? Una Serie Europea Tranquiliza en Ambos Sentidos

Michael O'Riordan

May 02, 2016

News Daily News

TAVR 是否需要预扩张？欧洲系列研究对两者都提供支持

Michael O'Riordan

May 02, 2016

News Daily News

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Michael O'Riordan

April 25, 2016

News Daily News

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Michael O'Riordan

April 25, 2016

Advertisement

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

大规模 Meta 分析显示，TAVR 与手术 30 天和 1 年死亡率相当

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

尽管有指南说明，但糖尿病患者多支 CAD 患者接受 PCI 的人数仍多于 CABG

A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

高风险 PCI 的机械循环支持：设备、时间、术者和方式的指南

Soporte Circulatorio Mecánico en PCI de Alto Riesgo: Guía para Saber Cuándo y Cómo

¿Predilatación o No Predilatación en TAVR? Una Serie Europea Tranquiliza en Ambos Sentidos

TAVR 是否需要预扩张？欧洲系列研究对两者都提供支持

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content